Enbrel and Remicade), p38 inhibitors, adenosine Al receptor agonists (e.g., R-PIA), somatostatin analogs, semapimod (CNI1493), caspase inhibitors, STAT inhibitors, JAK inhibitors, Trp channel inhibitors (e.g., BCTC), MET channel and other ion channel inhibitors, OCT2 transporter inhibitors (e.g., trospium chloride), CTR1 transporter inhibitors, and inhibitors of cyclin-dependent kinases, including CDK2 inhibitors
detox support
Age-related GH decline: physician-supervised GH axis support in patients with documented decline in endogenous GH secretion associated with aging Body composition: fat oxidation and lean mass preservation, particularly in patients seeking body composition improvements where GH optimization is clinically relevant Sleep quality and recovery: bedtime dosing protocols aimed at enhancing the natural nocturnal GH peak during slow-wave sleep Bone density support: GH-mediated osteoblast activity and IGF-1 signaling in patients with age-related bone density concerns Exercise performance and recovery: protein synthesis support and reduced recovery time from physical training Anti-aging and longevity protocols: GH axis optimization as one component of a comprehensive physician-directed longevity program Ipamorelin is among the most frequently prescribed growth hormone-related peptides in physician-supervised longevity and anti-aging medicine
To date, these conclusions have mostly been drawn from retrospective studies and meta-analyses, and prospective studies are warranted to validate these findings
Biochemical responses of the marine mussel Mytilus galloprovincialis to petrochemical environmental contamination along the Northwestern coast of Portugal
